News und Analysen
Solo Brands cooked on 2023 guidance cut. Is it a bargain or trap?
Outdoor and lifestyle products maker Solo Brands Inc. (NASDAQ: DTC) has grown a cultlike following under its many brands. The consumer discretionary sector company initially started by offering an
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. 133% Biotech Aktientip nach 15.973%
17.01.24 08:02
London (www.aktiencheck.de, Anzeige)
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare
QuantumScape surges on solid-state EV battery: Hype or home run?
QuantumScape Co. (NYSE: QS) has been developing the next-generation solid-state lithium-metal batteries for electric vehicles (EV). The Auto/tires/trucks sector company has been developing and
PayPal gearing up for a breakout despite shifting sentiment
Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,
Bitcoin ETFs: A two-day ranking of top performers
The recent approval and launch of eleven Bitcoin spot ETFs have added a thrilling chapter. Building up to the much-anticipated approval, the market was brimming with anticipation.
As the U.S.
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves
Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen
16.01.24
London (www.aktiencheck.de, Anzeige)
Lululemon stock falls on raised guidance
Premium athleisure brand Lululemon Athletica Inc. (NASDAQ: LULU) entered the holiday shopping season with solid momentum, sending shares through its all-time highs and peaking at $516.39 on Dec
3 retailers to compound your wealth this cycle
Today's market is the epitome of opportunity for those who know where to look. Considering that most market analysts suggest the stock market is overvalued today, by measures such as the Buffett
Insidertrades.com uncovers the hottest insider activity from 2023
Insider activity can be a telling indicator of where a stock is heading, and the activity was hot in 2023. This is a look at the hottest insider trades tracked by Insidertrades.com. Within it are
Rising credit card delinquencies make these stocks your safer bet
The credit cycle, as well as the business cycle in the United States economy, is getting underway for a major pivot coming into 2024. Whether you are a long-term investor or enjoy dabbling in and
3 stocks to keep in mind as a Red Sea conflict emerges
Every cycle brings about its own set of surprises, ones that, by their very own definition, are quite unpredictable. Today, the market and investors, just like you, may have been accustomed to a
These 4 factors driving growth of young fintech stock Tradeweb
You know those stocks from arcane industries that don’t get all the attention of, say Apple Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT) or Nvidia Corp. (NASDAQ: NVDA)?
Intel, Mobileye, Microchip see slowdown in automotive chip orders
When autonomous driving tech specialist Mobileye Global Inc. (NASDAQ: MBLY) got smacked down on January 4 on a surprise cut in its revenue forecast, it was signaling trouble throughout the
Eilt: Institutionelle Investoren unmittelbar vor Einstieg - Massives Kaufsignal. Neuer 156% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 156% mit Biotec
Eilt: Institutionelle Investoren unmittelbar vor Einstieg - Kaufsignal. 165% Biotech Hot Stock nach 15.973% mit BioNTech
15.01.24 08:03
London (www.aktiencheck.de , Anzeige)
APRISCO ENERGY INDUSTRIES Joins Forces with MAXIMANCE 2030 LTD and BLUEGRACE ENERGY BOLIVIA in a Cooperation Agreement for REDD+ Initiatives
BARCELONA, SPAIN / ACCESSWIRE / January 15, 2024 / APRISCO ENERGY INDUSTRIES S.L., a Spain-based company dedicated to a fair and sustainable energy transition, has joined forces with
UnitedHealth Group Looks Buyable After AI-Fueled Double Beat
The big banks will get the headlines, but investors should watch UnitedHealth Group Inc. (NYSE: UNH). The health insurance giant scored a double beat when it reported fourth-quarter earnings on
20% upside for JPMorgan Chase stock? Here’s how
Shares of JPMorgan Chase & Co. (NYSE: JPM) surged more than 5% immediately following the Q4 earnings release. The release aside, the move higher has extremely bullish implications for this market
Super Micro's super surge: 18.87% gain to begin the year
Super Micro Computer Inc. (NASDAQ: SMCI) started 2024 with a bang, rallying 18.87% in the past week.
The stock is in a buy zone, trading just below its January 10 high of $357.99.
The company's
Nvidia's skyrocketing journey into 2024
Last year’s hottest stock, Nvidia (NASDAQ: NVDA), has begun the new year the same way it ended its previous year. As you most likely know, shares of the chipmaker were up a staggering 239% in
4 reasons American Airlines stock could fly 40% higher in 2024
American Airlines Group Inc. (NASDAQ:AAL) is offering winter getaway packages to destinations like Cancun and Miami starting around $300. Such deals aren’t the only thing people are warming up to
Infosys stock sets up for growth, supported by AI
Infosys (NYSE: INFY) is an emergent player in AI for several reasons, including its impact on operations, potential client offerings, and demand for services from businesses looking to capitalize
Semiconductor sales grow; acceleration is in the forecast
Two primary themes were present in semiconductor markets in 2023: AI and normalization. For some, like NVIDIA (NASDAQ: NVDA), the AI boom led to wicked growth and skyrocketing share prices, while
